A Study of FZ-AD005 in Patients With Advanced Solid Tumors

NCT06424665 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)

Interventions

DRUG: FZ-AD005

Sponsor

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.